InvestorsHub Logo
Followers 32
Posts 5229
Boards Moderated 0
Alias Born 03/25/2013

Re: None

Thursday, 06/30/2022 1:50:03 PM

Thursday, June 30, 2022 1:50:03 PM

Post# of 426269
AF and Herper have had it out for AMRN for years. These two are like bad pennies always turning up. BioTech is a cutthroat business and I suspect some big players are pulling their strings to continue the assault on Vascepa.

Some people clearly want this company to fail for daring to change the CV industry. I hoped some BP would buy the drug but instead it looks like they would rather use their paid puppets to choke it out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News